Search results for "Immunization"
ACP recognizes August as National Immunization Awareness Month, urges adults to get vaccinated
Resources available from ACP include immunization patient education materials, the I Raise the Rates initiative, and the ACP Practice Advisor Adult Immunization Module.
https://immattersacp.org/weekly/archives/2017/08/01/6.htm
1 Aug 2017
Q&A with ACP's President on COVID-19 vaccines
George M. Abraham, MD, MPH, MACP, ACP's President, recently discussed the difference between third shots and boosters and other complexities of vaccination, as well as offered advice to internists on getting more patients vaccinated.
https://immattersacp.org/weekly/archives/2021/11/23/1.htm
23 Nov 2021
Latest COVID-19 research details local vaccine reactions, ineffective outpatient treatments
A case series described delayed skin reactions to vaccination, and randomized trials indicated that ivermectin, azithromycin, and convalescent plasma didn't help mildly ill patients. Several studies focused on the increase in alcohol use during the pandemic.
https://immattersacp.org/weekly/archives/2021/03/09/1.htm
9 Mar 2021
Latest COVID-19 research looks at vaccines' efficacy, thrombocytopenia risk
Thrombosis with thrombocytopenia is a risk with the Johnson & Johnson (Janssen) vaccine, but not those using mRNA technology, one study found, while other research quantified the vaccines' effectiveness over time. A trial found that monoclonal antibodies reduced progression from asymptomatic to symptomatic infection.
https://immattersacp.org/weekly/archives/2022/01/18/1.htm
18 Jan 2022
New data on delta variant of COVID-19 and vaccines
Recent research found that the risk of myocarditis and both arterial and venous clots is higher with COVID-19 infection than with vaccine administration. Other studies show that the COVID-19 delta variant has been associated with reduced mRNA vaccine effectiveness (from 91% to 66%) and an overall increased severity of illness.
https://immattersacp.org/weekly/archives/2021/08/31/1.htm
31 Aug 2021
Studies assess responses, reactions to vaccines; long-term effects of COVID-19 infection
Recent COVID-19 vaccine studies showed good response in pregnant women, as well as possible localized rashes from the Moderna vaccine. Analyses of ICU patients and those treated at a post-COVID-19 clinic highlighted the long-term effects of the virus, and a study found that dialysis patients maintained antibodies six months after COVID-19 infection.
https://immattersacp.org/weekly/archives/2021/05/18/1.htm
18 May 2021
Research, regulators consider booster dose of COVID-19 vaccine
FDA advisors recommended boosters for older and high-risk patients. The latest COVID-19 research looked at vaccine effectiveness, remdesivir's effects, an early indicator of vaccine-induced immune thrombotic thrombocytopenia, and rates of follow-up after hospitalization.
https://immattersacp.org/weekly/archives/2021/09/21/1.htm
21 Sep 2021
New research on mixed vaccine boosters, long-term outcomes, omicron severity
A study found mixing and matching of COVID-19 vaccines to be safe and effective, other research showed ongoing symptoms to be common at one year after infection, the CDC analyzed the severity of omicron, and the FDA revised outpatient treatment authorizations.
https://immattersacp.org/weekly/archives/2022/02/01/1.htm
1 Feb 2022
MKSAP Quiz: Routine visit for a patient with chronic kidney disease
A 45-year-old man is evaluated during a routine visit in September. He has advanced chronic kidney disease due to IgA nephropathy. After his vaccination history is evaluated, what is the most appropriate additional vaccine to administer at this visit?
https://immattersacp.org/weekly/archives/2023/07/18/3.htm
18 Jul 2023
Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies
The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021